European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: Validation with Italian data

Eric A F Simões, Xavier Carbonell-Estrany, John R. Fullarton, Giovanni A. Rossi, Ignazio Barberi, Marcello Lanari

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives. A model for predicting respiratory syncytial virus hospitalization in infants born 33-35 weeks' gestational age (wGA) has been developed from the Spanish FLIP study risk factors. The model correctly classified 71% of cases and the area under the receiver operating characteristic (ROC) curve was 0.791. To assess its applicability in Italy, the model was validated against data from the Osservatorio VRS study. Methods. Discriminant function analysis was used to validate the model by (a) using the predictive variables identified in FLIP to generate a function from the Italian data and (b) applying the coefficients from the FLIP calculations to the Italian data. Results. The function calculated from the Italian data provided 77% accurate classification (ROC: 0.773). Applying the FLIP coefficients to the Italian data resulted in correctly classifying 68% of cases and a ROC of 0.760. The number needed to treat to prevent hospitalization of 80% of at risk infants was 13.4, based on a hospitalization rate of 5% and 80% treatment efficacy. Conclusions. The Italian data confirm the predictive ability of the model, which could be used to target palivizumab prophylaxis in Italian infants born 33-35 wGA.

Original languageEnglish
Pages (from-to)152-157
Number of pages6
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume24
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Respiratory Syncytial Viruses
Premature Infants
ROC Curve
Gestational Age
Hospitalization
Numbers Needed To Treat
Discriminant Analysis
Italy

Keywords

  • 3335 weeks' gestational age
  • hospitalization
  • premature infants
  • respiratory syncytial virus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus : Validation with Italian data. / Simões, Eric A F; Carbonell-Estrany, Xavier; Fullarton, John R.; Rossi, Giovanni A.; Barberi, Ignazio; Lanari, Marcello.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 24, No. 1, 01.2011, p. 152-157.

Research output: Contribution to journalArticle

Simões, Eric A F ; Carbonell-Estrany, Xavier ; Fullarton, John R. ; Rossi, Giovanni A. ; Barberi, Ignazio ; Lanari, Marcello. / European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus : Validation with Italian data. In: Journal of Maternal-Fetal and Neonatal Medicine. 2011 ; Vol. 24, No. 1. pp. 152-157.
@article{fcd1b3efcbd4434bb589a125fe62f75b,
title = "European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: Validation with Italian data",
abstract = "Objectives. A model for predicting respiratory syncytial virus hospitalization in infants born 33-35 weeks' gestational age (wGA) has been developed from the Spanish FLIP study risk factors. The model correctly classified 71{\%} of cases and the area under the receiver operating characteristic (ROC) curve was 0.791. To assess its applicability in Italy, the model was validated against data from the Osservatorio VRS study. Methods. Discriminant function analysis was used to validate the model by (a) using the predictive variables identified in FLIP to generate a function from the Italian data and (b) applying the coefficients from the FLIP calculations to the Italian data. Results. The function calculated from the Italian data provided 77{\%} accurate classification (ROC: 0.773). Applying the FLIP coefficients to the Italian data resulted in correctly classifying 68{\%} of cases and a ROC of 0.760. The number needed to treat to prevent hospitalization of 80{\%} of at risk infants was 13.4, based on a hospitalization rate of 5{\%} and 80{\%} treatment efficacy. Conclusions. The Italian data confirm the predictive ability of the model, which could be used to target palivizumab prophylaxis in Italian infants born 33-35 wGA.",
keywords = "3335 weeks' gestational age, hospitalization, premature infants, respiratory syncytial virus",
author = "Sim{\~o}es, {Eric A F} and Xavier Carbonell-Estrany and Fullarton, {John R.} and Rossi, {Giovanni A.} and Ignazio Barberi and Marcello Lanari",
year = "2011",
month = "1",
doi = "10.3109/14767058.2010.482610",
language = "English",
volume = "24",
pages = "152--157",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus

T2 - Validation with Italian data

AU - Simões, Eric A F

AU - Carbonell-Estrany, Xavier

AU - Fullarton, John R.

AU - Rossi, Giovanni A.

AU - Barberi, Ignazio

AU - Lanari, Marcello

PY - 2011/1

Y1 - 2011/1

N2 - Objectives. A model for predicting respiratory syncytial virus hospitalization in infants born 33-35 weeks' gestational age (wGA) has been developed from the Spanish FLIP study risk factors. The model correctly classified 71% of cases and the area under the receiver operating characteristic (ROC) curve was 0.791. To assess its applicability in Italy, the model was validated against data from the Osservatorio VRS study. Methods. Discriminant function analysis was used to validate the model by (a) using the predictive variables identified in FLIP to generate a function from the Italian data and (b) applying the coefficients from the FLIP calculations to the Italian data. Results. The function calculated from the Italian data provided 77% accurate classification (ROC: 0.773). Applying the FLIP coefficients to the Italian data resulted in correctly classifying 68% of cases and a ROC of 0.760. The number needed to treat to prevent hospitalization of 80% of at risk infants was 13.4, based on a hospitalization rate of 5% and 80% treatment efficacy. Conclusions. The Italian data confirm the predictive ability of the model, which could be used to target palivizumab prophylaxis in Italian infants born 33-35 wGA.

AB - Objectives. A model for predicting respiratory syncytial virus hospitalization in infants born 33-35 weeks' gestational age (wGA) has been developed from the Spanish FLIP study risk factors. The model correctly classified 71% of cases and the area under the receiver operating characteristic (ROC) curve was 0.791. To assess its applicability in Italy, the model was validated against data from the Osservatorio VRS study. Methods. Discriminant function analysis was used to validate the model by (a) using the predictive variables identified in FLIP to generate a function from the Italian data and (b) applying the coefficients from the FLIP calculations to the Italian data. Results. The function calculated from the Italian data provided 77% accurate classification (ROC: 0.773). Applying the FLIP coefficients to the Italian data resulted in correctly classifying 68% of cases and a ROC of 0.760. The number needed to treat to prevent hospitalization of 80% of at risk infants was 13.4, based on a hospitalization rate of 5% and 80% treatment efficacy. Conclusions. The Italian data confirm the predictive ability of the model, which could be used to target palivizumab prophylaxis in Italian infants born 33-35 wGA.

KW - 3335 weeks' gestational age

KW - hospitalization

KW - premature infants

KW - respiratory syncytial virus

UR - http://www.scopus.com/inward/record.url?scp=78650125715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650125715&partnerID=8YFLogxK

U2 - 10.3109/14767058.2010.482610

DO - 10.3109/14767058.2010.482610

M3 - Article

C2 - 20486882

AN - SCOPUS:78650125715

VL - 24

SP - 152

EP - 157

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 1

ER -